Abstract
Staphylococcus pasteuri is a coagulase-negative, Gram positive organism which is emerging as an agent of nosocomial infections and a blood derivatives contaminant, though its role in causing human disease mostly remains controversial. Despite the paucity of isolates recovered, this bacterium has recently appeared to express resistance against several classes of antibiotic compounds, such as methicillin/oxacillin, macrolides, lincosamides, streptogramins, tetracyclines, chloramphenicol, streptomycin, fosfomycin, as well as quaternary ammonium compounds. Also, authors will discuss some essential patents related to the topic reviewed.
Keywords: Staphylococcus pasteuri, methicillin, oxacillin, macrolide, lincosamide, streptogramin, tetracyclines, chloramphenicol, fosfomycin
Recent Patents on Anti-Infective Drug Discovery
Title: Epidemiology, Pathogenicity and Emerging Resistances in Staphylococcus pasteuri: From Mammals and Lampreys, to Man
Volume: 4 Issue: 2
Author(s): Vincenzo Savini, Chiara Catavitello, Azaira Bianco, Andrea Balbinot and Domenico D'Antonio
Affiliation:
Keywords: Staphylococcus pasteuri, methicillin, oxacillin, macrolide, lincosamide, streptogramin, tetracyclines, chloramphenicol, fosfomycin
Abstract: Staphylococcus pasteuri is a coagulase-negative, Gram positive organism which is emerging as an agent of nosocomial infections and a blood derivatives contaminant, though its role in causing human disease mostly remains controversial. Despite the paucity of isolates recovered, this bacterium has recently appeared to express resistance against several classes of antibiotic compounds, such as methicillin/oxacillin, macrolides, lincosamides, streptogramins, tetracyclines, chloramphenicol, streptomycin, fosfomycin, as well as quaternary ammonium compounds. Also, authors will discuss some essential patents related to the topic reviewed.
Export Options
About this article
Cite this article as:
Savini Vincenzo, Catavitello Chiara, Bianco Azaira, Balbinot Andrea and D'Antonio Domenico, Epidemiology, Pathogenicity and Emerging Resistances in Staphylococcus pasteuri: From Mammals and Lampreys, to Man, Recent Patents on Anti-Infective Drug Discovery 2009; 4 (2) . https://dx.doi.org/10.2174/157489109788490352
DOI https://dx.doi.org/10.2174/157489109788490352 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
The Fibroblast Growth Factor 23: A New Player in the Field of Cardiovascular, Bone and Renal Disease
Current Vascular Pharmacology Chemistry and Pharmacology of Neglected Helminthic Diseases
Current Medicinal Chemistry Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Current Drug Targets Antiplatelet Agents in Cardiology: A Report on Aspirin, Clopidogrel, Prasugrel, and Ticagrelor
Current Pharmaceutical Design Stress, Cardiovascular Diseases and Surgery-Induced Angiogenesis
Current Angiogenesis (Discontinued) Strain Imaging Echocardiography: What Imaging Cardiologists Should Know
Current Cardiology Reviews Acute Respiratory Failure in Obstetric Patients
Current Women`s Health Reviews Applications of FDG-PET/CT in Assessment of Vascular Infection and Inflammation
Current Molecular Imaging (Discontinued) Current Developments in Therapeutic and Diagnostic Strategies for Q Fever: Glimpses of Patent Analysis
Recent Patents on Anti-Infective Drug Discovery Ventilation Therapy for Patients Suffering from Obstructive Lung Diseases
Recent Patents on Inflammation & Allergy Drug Discovery In Situ Oxidative Stress and Atrial Cell Deaths in Patients with Valve Disease
Cardiovascular & Hematological Disorders-Drug Targets Heart Failure in Acute Ischemic Stroke
Current Cardiology Reviews Sol Gel Method Performed for Biomedical Products Implementation
Mini-Reviews in Medicinal Chemistry Cellular Mechanisms for Diastolic Dysfunction in the Human Heart
Current Pharmaceutical Biotechnology Lipid Management for the Prevention of Cardiovascular Disease
Current Pharmaceutical Design Plasma-Activated Solutions for Bacteria and Biofilm Inactivation
Current Bioactive Compounds Coarctation of the Aorta - An Evolution of Therapeutic Options
Current Cardiology Reviews Surgical Ventricular Restoration: An Operation To Reverse Remodeling - The Basic Science (Part I)
Current Cardiology Reviews Fluoroquinolones, the Cornerstone of Treatment of Drug-Resistant Tuberculosis: A Pharmacokinetic and Pharmacodynamic Approach
Current Pharmaceutical Design Metalloproteinase-Mediated Shedding of Heparin-Binding Egf-Like Growth Factor and Its Pathophysiological Roles
Protein & Peptide Letters